CCK acts at the vagal afferent CCK1R to mediate postprandial satiety; however, while full agonist drugs of this receptor have stimulated weight reduction in patients, they have not achieved the primary end point of exceeding the effectiveness of acute dieting in clinical trials for obesity (31). This evidence concerns the gene CCKAR and obesity due to melanocortin 4 receptor deficiency.